|Articles|June 16, 2020
- PharmTech Sponsored eBooks-07-20-2020
- Volume Sponsored eBook
- Issue 10
Identifying and Quantifying Mutagenic Impurities in Pharmaceutical Products
Meeting detection challenges presented by nitrosamine impurities Determination of NDMA and nitrosamine impurities using triple-quadrupole LC/MS Determination of genotoxic impurities in ranitidine APIs and drug products
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Related Content
Trending on Pharmaceutical Technology
1
The Year of AI: 2025’s Bio/pharma Upskilling Revolution
2
Strategies for Building Pharmaceutical Supply Chain Resilience in a Shifting Market
3
Onshoring Requires a Plan for Training
4
Harnessing Data and Secure Cloud Environments for Global Pharma Solutions
5